MARKET

ILMN

ILMN

Illumina Inc
NASDAQ
114.49
-1.30
-1.12%
After Hours: 114.70 +0.21 +0.18% 19:55 07/19 EDT
OPEN
115.43
PREV CLOSE
115.79
HIGH
116.21
LOW
113.32
VOLUME
1.37M
TURNOVER
0
52 WEEK HIGH
195.64
52 WEEK LOW
86.49
MARKET CAP
18.24B
P/E (TTM)
-14.0422
1D
5D
1M
3M
1Y
5Y
1D
Oracle CEO Safra Catz to depart Walt Disney board
Oracle CEO Safra Catz to depart Walt Disney board after six years. Catz was elected to Disney's board in 2017. Disney CEO Robert Iger says Catz has provided invaluable insight to the entertainment company's strategic planning. Following Catz's departure, Walt Disney will be down to 11 members.
Reuters · 2d ago
Patient Capital Management Q2 2024 Investment Review
Seeking Alpha · 3d ago
Patient Capital Management Q2 2024 Commentary
Best investments begin in a state of obscurity, neglect or disdain. We see strong demand and high expectations for quality compounders, AI and technology. Only 26.4% of the S&P 500 constituents outperformed the index in the second quarter. High expectations are not the investor's friend.
Seeking Alpha · 3d ago
IJH, ILMN, LII, EME: ETF Inflow Alert
NASDAQ · 3d ago
NIH outlays rise by 5% in June, says Baird
Seeking Alpha · 5d ago
Weekly Report: what happened at ILMN last week (0708-0712)?
Weekly Report · 6d ago
What's Happening With Illumina Stock?
NASDAQ · 07/15 02:55
These are the stocks with the highest increase in short interest within life sciences and diagnostics - Baird
Exact Sciences Corp. Had the highest percentage increase in shares sold short within the life sciences and diagnostics sector at the end of June vs. The prior month. Five stocks within the sector saw more than 10% increase in short interest through May. Twist Bioscience had the lowest percentage of short interest in the sector.
Seeking Alpha · 07/12 18:30
More
About ILMN
Illumina, Inc. is engaged in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Its products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its product categories include Instruments, Kits & Reagents, Selection Tools, and Software & Analysis. Its Instruments category include sequencing platforms, microarray scanners, and IVD instruments. Its Kits & Reagents category consists of library preparation kits, sequencing reagents, microarray kits, clinical research products, and IVD products. Its Selection Tools category include Library Prep & Array Kit Selector, Gene Panel & Array Finder, DesignStudio Custom Assay Designer, and other. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training. It is also a developer of an emerging and highly differentiated single-cell technology.

Webull offers Illumina Inc stock information, including NASDAQ: ILMN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ILMN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ILMN stock methods without spending real money on the virtual paper trading platform.